Clinical Trial Update: Effect of the Biomarker Copeptin in Managing Patients With Suspected Acute Coronary Syndrome (ACS) [NA]

View source ↗

Summary

The clinical trial studying copeptin as a biomarker to guide management in patients with suspected acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Acute Myocardial Infarction | NA | Status: COMPLETED